Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tulinsky

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1993
Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide AB E Maryanoff, X Qiu, K P Padmanabhan, et al.
Journal of Medicinal Chemistry|November 8, 1996
Potent and selective thrombin inhibitors incorporating the constrained arginine mimic l-3-piperidyl(N-guanidino)alanine at P1O E Levy, J E Semple, M L Lim, et al.
Journal of Medicinal Chemistry|August 2, 1996
Potent thrombin inhibitors that probe the S1 subsite: tripeptide transition state analogues based on a heterocycle-activated carbonyl groupM J Costanzo, B E Maryanoff, L R Hecker, et al.
Journal of Medicinal Chemistry|November 8, 1996
Design, synthesis, and evolution of a novel, selective, and orally bioavailable class of thrombin inhibitors: P1-argininal derivatives incorporating P3-P4 lactam sulfonamide moietiesJ E Semple, D C Rowley, T K Brunck, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1993
Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide AB E Maryanoff, X Qiu, K P Padmanabhan, et al.
Journal of Medicinal Chemistry|November 8, 1996
Potent and selective thrombin inhibitors incorporating the constrained arginine mimic l-3-piperidyl(N-guanidino)alanine at P1O E Levy, J E Semple, M L Lim, et al.
Journal of Medicinal Chemistry|August 2, 1996
Potent thrombin inhibitors that probe the S1 subsite: tripeptide transition state analogues based on a heterocycle-activated carbonyl groupM J Costanzo, B E Maryanoff, L R Hecker, et al.
Journal of Medicinal Chemistry|November 8, 1996
Design, synthesis, and evolution of a novel, selective, and orally bioavailable class of thrombin inhibitors: P1-argininal derivatives incorporating P3-P4 lactam sulfonamide moietiesJ E Semple, D C Rowley, T K Brunck, et al.
Pageof 11